| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Biophysical Journal 50: 1079-1093 (1986)
© 1986 the Biophysical Society
ABSTRACT
The structural basis of the wide variability of the physical properties of fibrin clots and the process of assembly of the clot were investigated by electron microscopy of fibers formed under various ionic conditions. In addition, highly specific proteolytic enzymes from different snake venoms were used to remove selectively only the A (batroxobin) or the B (venzyme) fibrinopeptides from fibrinogen, in contrast to thrombin, which removes both pairs. Fibers produced by cleavage of only the B fibrinopeptides displayed a characteristic band pattern indistinguishable from that of fibers formed upon removal of either the A fibrinopeptides alone or of both pairs. Computer modeling studies suggest that there is a unique molecular packing that gives rise to this fibrin band pattern. These findings imply that the release of either fibrinopeptide triggers similar modes of aggregation; the intermolecular binding sites can be localized to particular molecular domains. The diameters of fibers formed with each condition of enzyme, pH, salt concentration, and temperature were measured from electron micrographs. All fibers, except for those produced at both high ionic strength and pH, had about the same average diameter of 85 +/- 13 nm. The degree of lateral aggregation of the fibers themselves varied greatly, however; fibers aggregated more readily with cleavage of both pairs of fibrinopeptides and at lower pH and salt concentrations. The formation of such thick fiber bundles increases the stability of the clot and its resistance to proteolytic dissolution.
This article has been cited by other articles:
 |
|
 |
|
  I. N. Chernysh and J. W. Weisel Dynamic imaging of fibrin network formation correlated with other measures of polymerization Blood, May 15, 2008; 111(10): 4854 - 4861. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Park, H.-J. Doh, S.-S. A. An, J.-R. Choi, K.-H. Chung, and K.-S. Song A novel fibrinogen variant (fibrinogen Seoul II; A{alpha}Gln328Pro) characterized by impaired fibrin {alpha}-chain cross-linking Blood, September 15, 2006; 108(6): 1919 - 1924. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. I. Litvinov, O. V. Gorkun, S. F. Owen, H. Shuman, and J. W. Weisel Polymerization of fibrin: specificity, strength, and stability of knob-hole interactions studied at the single-molecule level Blood, November 1, 2005; 106(9): 2944 - 2951. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Keller, J. Martinez, T. C. Baradet, C. Nagaswami, I. N. Chernysh, M. K. Borowski, S. Surrey, and J. W. Weisel Fibrinogen Philadelphia, a hypodysfibrinogenemia characterized by abnormal polymerization and fibrinogen hypercatabolism due to {gamma} S378P mutation Blood, April 15, 2005; 105(8): 3162 - 3168. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Moen, O. V. Gorkun, J. W. Weisel, and S. T. Lord Recombinant B{beta}Arg14His fibrinogen implies participation of N-terminus of B{beta} chain in desA fibrin polymerization Blood, October 1, 2003; 102(7): 2466 - 2471. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Philippou, J. Rance, T. Myles, S. W. Hall, R. A. Ariens, P. J. Grant, L. Leung, and D. A. Lane Roles of Low Specificity and Cofactor Interaction Sites on Thrombin during Factor XIII Activation: COMPETITION FOR COFACTOR SITES ON THROMBIN DETERMINES ITS FATE J. Biol. Chem., August 22, 2003; 278(34): 32020 - 32026. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Shainoff, G. B. Smejkal, P. M. DiBello, S.-S. Sung, L. A. Bush, and E. Di Cera Allosteric Effects Potentiating the Release of the Second Fibrinopeptide A from Fibrinogen by Thrombin J. Biol. Chem., May 24, 2002; 277(22): 19367 - 19373. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. F. Standeven, R. A.S. Ariens, P. Whitaker, A. E. Ashcroft, J. W. Weisel, and P. J. Grant The Effect of Dimethylbiguanide on Thrombin Activity, FXIII Activation, Fibrin Polymerization, and Fibrin Clot Formation Diabetes, January 1, 2002; 51(1): 189 - 197. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. MATSUDA and T. SUGO Hereditary Disorders of Fibrinogen Ann. N.Y. Acad. Sci., June 1, 2001; 936(1): 65 - 88. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. MEDVED, G. TSURUPA, and S. YAKOVLEV Conformational Changes upon Conversion of Fibrinogen into Fibrin: The Mechanisms of Exposure of Cryptic Sites Ann. N.Y. Acad. Sci., June 1, 2001; 936(1): 185 - 204. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. C. LOUNES, N. OKUMURA, K. A. HOGAN, L. PING, and S. T. LORD Polymerization Site a Function Dependence on Structural Integrity of Its Nearby Calcium Binding Site Ann. N.Y. Acad. Sci., June 1, 2001; 936(1): 205 - 209. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. HOGAN, B. BOLLIGER, N. OKUMURA, and S. T. LORD The Formation of {beta} Fibrin Requires a Functional a Site Ann. N.Y. Acad. Sci., June 1, 2001; 936(1): 219 - 222. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. W. WEISEL and L. MEDVED The Structure and Function of the {alpha}C Domains of Fibrinogen Ann. N.Y. Acad. Sci., June 1, 2001; 936(1): 312 - 327. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Sahni and C. W. Francis Vascular endothelial growth factor binds to fibrinogen and fibrin and stimulates endothelial cell proliferation Blood, December 1, 2000; 96(12): 3772 - 3778. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. S. Ariens, H. Philippou, C. Nagaswami, J. W. Weisel, D. A. Lane, and P. J. Grant The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure Blood, August 1, 2000; 96(3): 988 - 995. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. E. Brummel, S. Butenas, and K. G. Mann An Integrated Study of Fibrinogen during Blood Coagulation J. Biol. Chem., August 6, 1999; 274(32): 22862 - 22870. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Veklich, C. W. Francis, J. White, and J. W. Weisel Structural Studies of Fibrinolysis by Electron Microscopy Blood, December 15, 1998; 92(12): 4721 - 4729. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. R. Hantgan, W. G. Jerome, and M. J. Hursting No Effect of Clot Age or Thrombolysis on Argatroban's Inhibition of Thrombin Blood, September 15, 1998; 92(6): 2064 - 2074. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Shainoff, G. B. Smejkal, P. M. DiBello, O. V. Mitkevich, P. J. Levy, C. E. Dempfle, and H. Lill Isolation and Characterization of the Fibrin Intermediate Arising from Cleavage of One Fibrinopeptide A from Fibrinogen J. Biol. Chem., September 27, 1996; 271(39): 24129 - 24137. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. Hogan, O. V. Gorkun, K. C. Lounes, A. I. Coates, J. W. Weisel, R. R. Hantgan, and S. T. Lord Recombinant Fibrinogen Vlissingen/Frankfurt IV. THE DELETION OF RESIDUES 319 AND 320 FROM THE gamma CHAIN OF FIBRINOGEN ALTERS CALCIUM BINDING, FIBRIN POLYMERIZATION, CROSS-LINKING, AND PLATELET AGGREGATION J. Biol. Chem., June 2, 2000; 275(23): 17778 - 17785. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
